Assessment of spinal cord injury spasticity in clinical trials

Topics in Spinal Cord Injury Rehabilitation

Volumn 11, Issue 3, 2006, Pages 69-77

  Priebe, Michael M ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Assessment; Outcome measures; Review; Spasticity; Spinal cord injury

Indexed keywords

ASHWORTH SCALE; CLINICAL RESEARCH; HUMAN; MODIFIED ASHWORTH SCALE; MUSCLE SPASM; OUTCOMES RESEARCH; PATIENT EVALUATION CONFERENCE SYSTEM; PEDIATRIC EVALUATION OF DISABILITY INVENTORY; QUALITY OF LIFE; RATING SCALE; REVIEW; SICKNESS IMPACT PROFILE; SOCIAL PSYCHOLOGY; SPASM FREQUENCY SCALE; SPASTICITY; SPINAL CORD INJURY; VISUAL ANALOG SCALE; VISUAL FACES SCALE;

EID: 30344474596     PISSN: 10820744     EISSN: None     Source Type: Journal    
DOI: 10.1310/82XL-W79K-V6K2-DCWG     Document Type: Review

References (42)

1. Sköld C, Levi R, Seiger A. Spasticity after traumatic spinal cord injury: nature, severity and location. Arch Phys Med Rehabil. 1999; 80:1548-1557.
2. Maynard FM, Karunas R, Waring WW. Epidemiology of spasticity following traumatic spinal cord injury. Arch Phys Med Rehabil. 1990;71:566-569.
3. Levi R, Hultling C, Nash MS, Seiger A. The Stockholm Spinal Cord Injury Study: 1. Medical problems in a regional SCI population. Paraplegia. 1995;33(6):308-315.
4. Sherwood AM, Graves DE, Priebe MM. Altered motor control and spasticity after spinal cord injury: subjective and objective assessment. J Rehabil Res Dev. 2000;37:41-52.
5. Lance JW. Symposium Synopsis. In: Feldman RG, Young RR, Koella WP, eds. Spasticity: Disordered Motor Control. Chicago: Mosby-Year Book; 1980:485-494.
6. Meritt JL. Management of spasticity in spinal cord injury. Mayo Clin Proc. 1981;56:614-622.
7. Young RR. Treatment of spastic paresis. N Engl J Med. 1989;320:1553-1555.
8. Sheean G. The pathophysiology of spasticity. Eur J Neurol. 2002;9(suppl 1):3-9, dicussion 53-61.
9. McKay WB, Lim HK, Priebe MM, Stokic DS, Sherwood AM. Clinical neurophysiological assessment of residual motor control in post-spinal cord injury paralysis. Neurorehabil Neural Repair. 2004;18:144-153.
10. Burridge JH, Wood DE, Hermens HJ, et al. Theoretical and methodological considerations in the measurement of spasticity. Disabil Rehabil. 2005;27:69-80.
11. Wu M, Hornby TG, Hilb J, Schmit BD. Extensor spasms triggered by imposed knee extension in chronic human spinal cord injury. Exp Brain Res. 2005;162:239-249.
12. Wu M, Hornby TG, Kahn JH, Schmit BD. Flexor reflex responses triggered by imposed knee extension in chronic human spinal cord injury. Exp Brain Res Online First. Available at: http://www.SpringerLink.com. Accessed September 7, 2005.
13. Little JW, Micklesen P, Umlauf R, Britell C. Lower extremity manifestations of spasticity in chronic spinal cord injury. Am J Phys Med Rehabil. 1989;68(1):32-36.
14. Barolat G, Maiman DJ. Spasms in spinal cord injury: a study of 72 subjects. J Am Paraplegia Soc. 1987;10(2):35-39.
15. Hornby TG, Rymer WZ, Benz EN, Schmit BD. Windup of flexion reflexes in chronic human spinal cord injury: a marker for neuronal plateau potentials? J Neurophysiol. 2003;89: 416-426.
16. Adams MM, Hicks AL. Spasticity after spinal cord injury. Spinal Cord. 2005;43:577-586.
17. Priebe MM, Sherwood AM, Thornby JI, et al. Clinical assessment of spasticity in spinal cord injury: a multidimensional problem. Arch Phys Med Rehabil. 1996;77:713-716.
18. Pierson SH. Outcome measures in spasticity management. Muscle Nerve. 1997;20(suppl 6):S36-S60.
19. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner. 1964;192: 540-542.
20. Pandyan A, Johnson G, Priece C, et al. A review of the properties and limitations of the Ashworth and modified Ashworth scales as measures of spasticity. Clin Rehabil. 1999;13: 373-383.
21. Bohannan RW, Smith MB. Inter-rater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67:206-207.
22. Haas BM, Bergstrom E, Jamous A, Bennie A. The inter-rater reliability of the original and of the modified Ashworth scale for assessment of spasticity in patients with spinal cord injury. Spinal Cord. 1996;34:560-564.
23. Johnson GR. Outcome measures of spasticity. Eur J Neurol. 2002;9(suppl 1):10-16.
24. Gracies JM. Pathophysiology of spastic paresis. 1: paresis and soft tissue changes. Muscle Nerve. 2005;31:535-551.
25. Levin MF. On the nature and measurement of spasticity [editorial]. Clin Neurophysiol. 2005;116:1754-1755.
26. Platz T, Eickhof C, Nuyens G, Vuadens P. Clinical scales for the assessment of spasticity, associated phenomena, and function: a systematic review of the literature. Disabil Rehabil. 2005;27:7-18.
27. Bajd T, Vodovnik L. Pendulum testing of spasticity. J Biomed Eng. 1984;6:9-16.
28. Litvan I, Mangone CA, Werner W, et al. Reliability of the NINDS Myotatic Reflex Scale. Neurology. 1996;47(4):969-972.
29. Loubser PG, Narayan RK, Sandin KL, et al. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia. 1991;41:865-873.
30. Benz EN, Hornby TG, Bode RK, Scheldt RA, Schmit BD. A physiologically based clinical measure for spastic reflexes in spinal cord injury. Arch Phys Med Rehabil. 2005;86:52-59.
31. Penn RD. Intrathecal baclofen for severe spasticity. Ann NY Acad Sci. 1988;531:157-166.
32. van Gijn J. The Babinski sign and the pyramidal syndrome. J Neurol Neurosurg Psychiatry. 1978;41:865-873.
33. Gruenthal M, Mueller M, Olson WL, Priebe MM, Sherwood AM, Olson WH. Gabapentin for the treatment of spasticity in patients with spinal cord injury. Spinal Cord. 1997;35:686-689.
34. Sköld C. Spasticity in spinal cord injury: self- and clinically rated intrinsic fluctuations and intervention-induced changes. Arch Phys Med Rehabil. 2000;81:144-149.
35. Hinderer SR, Gupta S. Functional outcome measures to assess interventions for spasticity. Arch Phys Med Rehabil. 1996;77(10):1083-1089.
36. Parke B, Penn RD, Savoy SM, Corcos D. Functional outcome after delivery of intrathecal baclofen. Arch Phys Med Rehabil. 1989;70(1): 30-32.
37. Dudgeon BJ, Libby AK, McLaughlin JF, Hays RM, Bjornson KF, Roberts TS. Prospective measurement of functional changes after selective dorsal rhizotomy. Arch Phys Med Rehabil. 1994;75(1):46-53.
38. Kesiktas N, Paker N, Erdogan N, Gulsen G, Bicki D, Yilmaz H. The use of hydrotherapy for the management of spasticity. Neurorehabil Neural Repair. 2004;18(4):268-273.
39. Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6-18.
40. Ferrans CE, Powers MJ. Psychometric assessment of the Quality of Life Index. Res Nurs Health. 1992;15(1):29-38.
41. Deyo RA, Inui TS, Leininger JD, Overman SS. Measuring functional outcomes in chronic disease: a comparison of traditional scales and a self-administered health status questionnaire in patients with rheumatoid arthritis. Med Care. 1983;21(2):180-192.
42. Gianino JM, York MM, Paice JA, Shott S. Quality of life: effect of reduced spasticity from intrathecal baclofen. J Neurosci Nurs. 1998; 30(1):47-54.